Search

for
Search:

Sort by

Research

510-540 / 1000+ results

Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets (HVDRR): Clinical Heterogeneity and Long-Term Efficacious Management of Eight Patients from Four Unrelated Arab Families with a Loss of Function VDR Mutation

research Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): clinical heterogeneity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation

6 citations , June 2018 in “Journal of pediatric endocrinology & metabolism/Journal of pediatric endocrinology and metabolism”

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

research Finasteride for Chronic Central Serous Chorioretinopathy

April 2014 in “Investigative Ophthalmology & Visual Science”

research A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.

12 citations , May 2010 in “Journal of Clinical Oncology”

MK-5108 is safe and shows potential against tumors, especially alone.

Induction of Secreted WNT Factor WISP1/CCN4 by Human Prostate Stromal Cells Under Microenvironmental Hypoxia

research 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA

April 2010 in “The Journal of Urology”

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

research A Study of Non-Scarring Diffuse Alopecia

May 2018 in “Journal of advanced research in medicine”

The document's conclusion cannot be provided because the document is not accessible or understandable.

Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata

research Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata

October 2025 in “Dermatology and Therapy”

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

research Mendeley Supplemental Document 1

January 2020

research Informàtica i Dret penal: Els delictes relatius a la informàtica

January 1996 in “Studia iuridica”

Two new gene mutations cause a rare hair disorder.

research KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models

15 citations , April 2001 in “Journal of Dermatological Science”

KF19418 promotes hair growth similarly to minoxidil but is not better in live mice.

research Hair Symposium 1996 — The New York Experience

July 1996 in “Hair transplant forum international”

The document's content couldn't be processed.

research miR‐203a‐3p promotes loureirin A‐induced hair follicle stem cells differentiation by targeting Smad1

12 citations , June 2020 in “The anatomical record”

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

research BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the AIRE gene mutation treated with ruxolitinib

June 2025 in “British Journal of Dermatology”

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The Estrogen Receptor 2 (ESR2) Gene in Female-Pattern Hair Loss: Replication of Association with rs10137185 in German Patients

research The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patients

4 citations , December 2013 in “British Journal of Dermatology”

ESR2 gene linked to female-pattern hair loss.

research Cyberspace Chat

September 2008 in “Hair transplant forum international”

research Cyberspace Chat

January 2007 in “International Society of Hair Restoration Surgery”

research 034 Characterization of novel TMEM173 mutation causing a lupus- and SAVI-like phenotype, modified by polymorphisms in TMEM173 and IFIH1

September 2019 in “The journal of investigative dermatology/Journal of investigative dermatology”

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

research CD169+ Skin Macrophages Function as a Specialized Subpopulation in Promoting Psoriasis-like Skin Disease in Mice

2 citations , May 2024 in “International Journal of Molecular Sciences”

Targeting CD169+ skin macrophages may help treat psoriasis.

research Society and Forum Separate Financially

September 1994 in “Hair transplant forum international”

The document's conclusion cannot be summarized because the content is not available.

research The investigation of selective sphingosine-1 phosphate receptor 1&4 modulator to treat alopecia areata mouse model 2881

November 2025 in “The Journal of Immunology”

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

research Generative Artificial Intelligence Tools: Evaluating Ways to Automate Your SALT ( GATEWAYS ) Scoring of Alopecia Areata

March 2026 in “Pediatric Dermatology”

research Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor

21 citations , April 2008 in “Toxicologic Pathology”

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

research First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.

33 citations , May 2017 in “Journal of Clinical Oncology”

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

research Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor

37 citations , August 2011 in “Journal of Bone and Mineral Research”

A girl had rickets due to a gene mutation affecting vitamin D response.

research 0196 Levamisole-induced pyoderma gangrenosum case report

1 citations , July 2025 in “Journal of Investigative Dermatology”

research Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program

March 2025 in “SKIN The Journal of Cutaneous Medicine”

research Genetic Variants at 20p11 Confer Risk to Androgenetic Alopecia in the Chinese Han Population

9 citations , August 2013 in “PLOS ONE”

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

research A Statistical Study of Dermatoses(1995-1999)

1 citations , January 2002 in “Journal of Clinical Dermatology”

The document's conclusion cannot be provided because the document is not accessible or understandable.

Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

research Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

January 2024 in “American journal of clinical dermatology”

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

research Construction of a cDNA library and identification of genes from Liaoning cashmere goat

6 citations , March 2014 in “Livestock science”

Researchers created a genetic library from a cashmere goat's skin and found new genes linked to hair growth.

research The Genetics of Seborrheic Dermatitis: A Candidate Gene Approach and Pilot Genome-Wide Association Study

15 citations , December 2017 in “Journal of Investigative Dermatology”

No strong genetic link to other skin conditions was found, but some genetic factors may make people more likely to get seborrheic dermatitis.

← Previous page Next page →